Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donors

American Journal of Transplantation

Volumn 12, Issue 12, 2012, Pages 3377-3386

  Khush, K K ^a   Pawlikowska, L ^b   Menza, R L ^c   Goldstein, B A ^a   Hayden, V ^d   Nguyen, J ^d   Kim, H ^e   Poon, A ^e   Sapru, A ^b   Matthay, M A ^b   Kwok, P Y ^e   Young, W L ^b   Baxter Lowe, L A ^e   Zaroff, J G ^f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^d California Transplant Donor Network   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DIVISION OF RESEARCH   (United States)

Author keywords

Allograft function; brain death; cardiac allograft; cardiac transplant; cohort study; donor evaluation; donor management; donor outcomes; genetic polymorphism; genotyping

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; DOPAMINE;

ADULT; ARTICLE; BRAIN DEATH; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; GRAFT DYSFUNCTION; HEART GRAFT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ORGAN DONOR; PRIORITY JOURNAL; RECEPTOR GENE; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BRAIN DEATH; FEMALE; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RETROSPECTIVE STUDIES; TISSUE DONORS; VALIDATION STUDIES AS TOPIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84870527261     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04266.x     Document Type: Article

References (32)

1. Goel R, Johnson F, Mehra MR,. Brain injury and ventricular dysfunction: Insights into reversible heart failure. Congest Heart Fail 2005; 11: 99-101.
2. Allman FD, Herold W, Bosso FJ, Pilati CF,. Time-dependent changes in norepinephrine-induced left ventricular dysfunction and histopathologic condition. J Heart Lung Transplant 1998; 17: 991-997.
3. Lang SA, Maron MB, Bosso FJ, Pilati CF,. Temporal changes in left ventricular function after massive sympathetic nervous system activation. Can J Physiol Pharmacol 1994; 72: 693-700.
4. Audibert G, Charpentier C, Seguin-Devaux C, et al,. Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation 2006; 82: 1031-1036.
5. Novitzky D, Horak A, Cooper DK, Rose AG,. Electrocardiographic and histopathologic changes developing during experimental brain death in the baboon. Transplant Proc 1989; 21 (1 Pt 3): 2567-2569.
6. Novitzky D, Wicomb WN, Cooper DK, Rose AG, Reichart B,. Prevention of myocardial injury during brain death by total cardiac sympathectomy in the Chacma baboon. Ann Thorac Surg 1986; 41: 520-524.
7. Samuels MA,. The brain-heart connection. Circulation 2007; 116: 77-84.
8. Zaroff JG, Babcock WD, Shiboski SC,. The impact of left ventricular dysfunction on cardiac donor transplant rates. J Heart Lung Transplant 2003; 22: 334-337.
9. Cockcroft JR, Gazis AG, Cross DJ, et al,. Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 2000; 36: 371-375.
10. Heckbert SR, Hindorff LA, Edwards KL, et al,. Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 2003; 107: 2021-2024.
11. Iwai C, Akita H, Kanazawa K, et al,. Arg389Gly polymorphism of the human beta1-adrenergic receptor in patients with nonfatal acute myocardial infarction. Am Heart J 2003; 146: 106-109.
12. Kanki H, Yang P, Xie HG, Kim RB, George AL Jr., Roden DM,. Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome. J Cardiovasc Electrophysiol 2002; 13: 252-256.
13. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB,. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002; 347: 1135-1142.
14. Zaroff JG, Pawlikowska L, Miss JC, et al,. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke 2006; 37: 1680-1685.
15. Hsu TM, Kwok PY,. Homogeneous primer extension assay with fluorescence polarization detection. Methods Mol Biol 2003; 212: 177-187.
16. Zaroff JG, Babcock WD, Shiboski SC, Solinger LL, Rosengard BR,. Temporal changes in left ventricular systolic function in heart donors: results of serial echocardiography. J Heart Lung Transplant 2003; 22: 383-388.
17. Zaroff JG, Rosengard BR, Armstrong WF, et al,. Consensus conference report: Maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation 2002; 106: 836-841.
18. Green SA, Turki J, Innis M, Liggett SB,. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33: 9414-9419.
19. Bisognano JD, Weinberger HD, Bohlmeyer TJ, et al,. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J Mol Cell Cardiol 2000; 32: 817-830.
20. Engelhardt S, Hein L, Wiesmann F, Lohse MJ,. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A 1999; 96: 7059-7064.
21. Mason DA, Moore JD, Green SA, Liggett SB,. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 1999; 274: 12670-12674.
22. Ranade K, Jorgenson E, Sheu WH, et al,. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002; 70: 935-942.
23. Hachinski VC, Smith KE, Silver MD, Gibson CJ, Ciriello J,. Acute myocardial and plasma catecholamine changes in experimental stroke. Stroke 1986; 17: 387-390.
24. Brodde OE, Michel MC,. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999; 51: 651-690.
25. Menon B, Singh M, Ross RS, Johnson JN, Singh K,. beta-Adrenergic receptor-stimulated apoptosis in adult cardiac myocytes involves MMP-2-mediated disruption of beta1 integrin signaling and mitochondrial pathway. Am J Physiol Cell Physiol 2006; 290: C254-C261.
26. Feldman RD,. Beta-adrenergic receptor alterations in hypertension- physiological and molecular correlates. Can J Physiol Pharmacol 1987; 65: 1666-1672.
27. Dishy V, Sofowora GG, Xie HG, et al,. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001; 345: 1030-1035.
28. Borjesson M, Magnusson Y, Hjalmarson A, Andersson B,. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 2000; 21: 1853-1858.
29. Owen VJ, Burton PB, Michel MC, et al,. Myocardial dysfunction in donor hearts. A possible etiology. Circulation 1999; 99: 2565-2570.
30. Gridelli B, Remuzzi G,. Strategies for making more organs available for transplantation. N Engl J Med 2000; 343: 404-410.
31. Hornby K, Ross H, Keshavjee S, Rao V, Shemie SD,. Non-utilization of hearts and lungs after consent for donation: A Canadian multicentre study. Can J Anaesth 2006; 53: 831-837.
32. White M, Wiechmann RJ, Roden RL, et al,. Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. Circulation 1995; 92: 2183-2189.